AIM ImmunoTech Inc (AIM)
0.121
-0.01
(-5.39%)
USD |
NYAM |
Mar 28, 16:00
0.1269
+0.01
(+4.88%)
After-Hours: 20:00
AIM ImmunoTech Total Liabilities (Quarterly): 10.68M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 50.43M |
| Protalix BioTherapeutics Inc | 30.21M |
| Electromed Inc | 8.671M |
| Xtant Medical Holdings Inc | 50.87M |
| Armata Pharmaceuticals Inc | 134.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.59M |
| Shareholders Equity (Quarterly) | 2.912M |
| Debt to Equity Ratio | 0.9382 |
| Current Ratio | 0.7495 |
| Net Debt Paydown Yield | -3.45% |